Fear of Cancer Recurrence in Women with Breast Cancer: A Cross-Sectional Study after Mastectomy

Abstract

Aim: The aim of this study was to determine the fear of cancer recurrence in women with breast cancer after mastectomy. Material and Methods: Data were collected between March and September 2021 with the Personal Information Form and the Fear of Cancer Recurrence Inventory via social media. The sample consisted of 127 women with breast cancer, who were registered in the general surgery service of a training and research hospital in Turkey, could be reached by phone and had a social media account. Descriptive statistics, independent groups t test, One-Way ANOVA and Mann-Whitney U test analysis were used in the analysis of the data. Results: It was determined that the Fear of Cancer Recurrence Inventory mean score was 126.12±24.88 and the coping strategies sub-dimension mean score was 30.96±6.00. It was determined that there was a significant difference between the mean score of the Fear of Cancer Recurrence Inventory and the duration of diagnosis, the status of receiving radiotherapy and chemotherapy, the status of experiencing treatment-related side effects, and the status of doing any sports/exercise (p<0.05). It was also determined that the average score of Fear of Cancer Recurrence Inventory was higher in women who did not receive radiotherapy and chemotherapy, did not experience treatment-related side effects, and did not do sports/exercise, between 1-12 months of diagnosis time (p<0.05). Conclusion: Health professionals should evaluate the concerns of women with breast cancer and their families about fear of cancer recurrence and help them develop strategies to support their coping.

Keywords

• Breast cancer
• mastectomy
• woman
• fear of cancer recurrence

Meme Kanserli Kadınlarda Kanserin Nüksetme Korkusu: Mastektomi Sonrası Kesitsel Bir Çalışma

Öz

Amaç: Bu çalışmanın amacı meme kanserli kadınlarda mastektomi sonrası kanserin nüksetme korkusunu belirlemektir. Materyal ve Metot: Tanımlayıcı ve kesitsel tipteki bu çalışmanın verileri, Kişisel Bilgi Formu ve Kanserin Nüksetme Korkusu Envanteri ile Mart-Eylül 2021 tarihleri arasında sosyal medya aracılığıyla toplanmıştır. Araştırmanın örneklemini, Türkiye’de bir eğitim ve araştırma hastanesinin genel cerrahi servisine kayıtlı, telefonla ulaşılabilen ve sosyal medya hesabı olan 127 meme kanserli kadın oluşturmuştur. Verilerin analizinde tanımlayıcı istatistikler, bağımsız gruplarda t testi, One-Way ANOVA ve Mann-Whitney U testi analizi kullanılmıştır. Bulgular: Araştırmada Kanserin Nüksetme Korkusu Envanteri puan ortalamasının 126.12±24.88 ve baş etme stratejileri alt boyutu puan ortalamasının 30.96±6.00 olduğu belirlendi. Kanserin Nüksetme Korkusu Envanteri puan ortalamaları ile tanı süresi, radyoterapi ve kemoterapi alma durumu, tedaviye bağlı yan etki yaşama durumu ve herhangi bir spor/egzersiz yapma durumu arasında anlamlı fark olduğu tespit edildi (p<0.05). Radyoterapi ve kemoterapi almayan, tedaviye bağlı yan etki yaşamayan, spor/egzersiz yapmayan ve tanı süresi 1-12 ay arasında olan kadınlarda Kanserin Nüksetme Korkusu Envanteri puan ortalamasının daha yüksek olduğu bulundu (p<0.05). Sonuç: Sağlık profesyonelleri meme kanserli kadınların ve ailelerinin kanserin nüksetme korkusuyla ilgili endişelerini değerlendirmeli ve baş etmelerini destekleyecek stratejiler geliştirmelerine yardımcı olmalıdır.

Anahtar Kelimeler

• Meme kanseri
• mastektomi
• kadın
• kanserin nüksetme korkusu

Kaynakça

1. 1. Fahad Ullah M. Breast Cancer: Current Perspectives on the Disease Status. Adv Exp Med Biol. 2019;1152:51-64.
2. 2. American Cancer Society. Cancer Facts & Figures 2016. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2016.html access date 01.11.2021.
3. 3. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu Kanser Daire Başkanlığı 2017 yılı Türkiye Kanser İstatistikleri. https://hsgm.saglik.gov.tr/tr/kanser-istatistikleri/yillar/2017-turkiye-kanser istatistikleri.html access date 01.11.2021.
4. 4. Gradishar WJ, Anderson BO, Abraham J, et al. Breast Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2021;19(5):541-65.
5. 5. American Cancer Society. Breast Cancer: Can Breast Cancer Be Found Early? http://www.cancer.org/cancer/breastcancer/detailedguide/breastcancer-detection?rnav=cri access date 01.11.2021.
6. 6. National Cancer Institute. Breast cancer screening. http://www.cancer.gov/cancertopics/pdq/screening/breast/healthprofessional access date 01.11.2021.
7. 7. Benson JR, Jatoi I, Keisch M, et al. Early breast cancer. Lancet. 2009;373(9673):1463-79.
8. 8. Özmen V. Breast Cancer Screening: current controversies. J Breast Health 2011;7(1):1-4.

9. 9. Lai WS, Shu BC, Hou WL. A qualitative exploration of the fear of recurrence among Taiwanese breast cancer survivors. Eur J Cancer Care 2019;28(5):e13113.
10. 10. Chae BJ, Lee J, Lee SK, et al. Unmet needs and related factors of Korean breast cancer survivors: a multicenter, cross-sectional study. BMC Canc 2019;19(839):2-16.
11. 11. Ellegaard MB, Grau C, Zachariae R, et al. Fear of cancer recurrence and unmet needs among breast cancer survivors in the first five years. A cross-sectional study. Acta Oncol 2017;56(2):314-20. 12. Lebel S, Ozakinci G, Humphris G, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer 2016;24(8):3265-8. 13. Custers JAE, Gielissen MFM, Janssen SHV, et al. Fear of cancer recurrence in colorectal cancer survivors. Support Care Cancer 2016;24(2):555-62.
12. 14. Freeman-Gibb LA, Janz NK, Katapodi MC, et al. The relationship between illness representations, risk perception and fear of cancer recurrence in breast cancer survivors. Psychooncology 2017;26(9):1270-7.
13. 15. Gotze H, Taubenheim S, Dietz A, et al. Fear of cancer recurrence across the survivorship trajectory: Results from a survey of adult long-term cancer survivors. Psychooncology 2019;28(10):2033-41.
14. 16. Hong SJ, Shin NM. Fear of cancer recurrence in Korean women after breast cancer treatment: A mixed methods study. Eur J Oncol Nurs 2021;54:102010.
15. 17. Simard S, Savard J, Ivers H. Fear of cancer recurrence: specific profiles and nature of intrusive thoughts. J Cancer Surviv 2010;4(4):361-71.
16. 18. Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: A systematic review of quantitative studies. J Cancer Surviv 2013;7(3):300-22.
17. 19. Butow P, Kelly S, Thewes B, et al. Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence. Psychooncology 2015; 24(4):416-23.
18. 20. Thewes B, Butow P, Bell ML, et al. Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer 2012;20(11):2651-9.
19. 21. Inan SF, Ustun B. Fear of recurrence in Turkish breast cancer survivors: A qualitative study. J Transcult Nurs 2019;30(2):146-53.
20. 22. Akyol A. Yetişkinde ölüm süreci ve hemşirelik bakımı. Ege Üniversitesi Hemşirelik Yüksek Okulu Dergisi 2010;26(3):59-72.
21. 23. Thewes B, Bell ML, Butow P. Fear of cancer recurrence in young early‐stage breast cancer survivors: the role of metacognitive style and disease‐related factors. Psychooncology 2013;22(9):2059-63.
22. 24. Hulley SB, Cummings SR, Browner WS, et al. Designing clinical research: an epidemiologic approach. Philadelphia, PA: Lippincott Williams & Wilkins.2013.
23. 25. Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 2009;17(3):241-51.
24. 26. Eyrenci A, Berk HÖS. Validity and reliability of the Turkish version of fear of cancer recurrence inventory. Turk J Oncol 2018;33(2):54-64.
25. 27. Koch L, Jansen L, Brenner H, et al. Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors--a systematic review of quantitative studies. Psychooncology 2013;22(1):1-11.
26. 28. Nilsson R, Næss-Andresen TF, Myklebust TÅ, et al. Fear of recurrence in prostate cancer patients: A cross-sectional study after radical prostatectomy or active surveillance. Eur Urol Open Sci 2021;25:44-51.
27. 29. Galica J, Giroux J, Francis JA, et al. Coping with fear of cancer recurrence among ovarian cancer survivors living in small urban and rural settings: A qualitative descriptive study. Eur J Oncol Nurs 2020;44:101705.
28. 30. Ahlstedt SK, Wallengren C, Olofsson RB, Henoch I. "It is not just any pill"-Women's experiences of endocrine therapy after breast cancer surgery. Eur J Cancer Care 2019;28(3):e13009.
29. 31. Chumdaeng S, Soivong P, Sethabouppha H, et al. Health problems among breast cancer survivors after completing conventional treatments: A cross-sectional study. Nurs Health Sci 2020;22(2):436-44.
30. 32. Lebel S, Beattie S, Arès I, et al. Young and worried: Age and fear of recurrence in breast cancer survivors. Health Psychol 2013;32(6):695-705.
31. 33. Thewes B, Lebel S, Seguin CL, et al. A qualitative exploration of fear of cancer recurrence (FCR) amongst Australian and Canadian breast cancer survivors. Support Care Cancer 2016;24(5):2269-76.
32. 34. De Vries J, Den Oudsten BL, Jacobs PM, et al. How breast cancer survivors cope with fear of recurrence: a focus group study. Support Care Cancer 2014;22(3):705-12.
33. 35. Cebeci F, Yangın HB, Tekeli A. Life experiences of women with breast cancer in south western Turkey: a qualitative study. Eur J Oncol Nurs 2012;16(4):406-12.
34. 36. Abbasi F, Pourjalali H, do Nascimento IJB, et al. The effects of exercise training on inflammatory biomarkers in patients with breast cancer: A systematic review and meta-analysis. Cytokine 2022;149:155712.
35. 37. Boing L, Vieira MCS, Moratelli J, et al. Effects of exercise on physical outcomes of breast cancer survivors receiving hormone therapy-A systematic review and meta-analysis. Maturitas 2020;141:71-81.